Quick News Bit

Madonna Revived by Narcan; Doc Assaults Employee; Semaglutide Compounders Sued

0

Note that some links may require subscriptions.

Madonna was reportedly found unresponsive and revived by a naloxone (Narcan) injection to combat acute septic shock before her ICU stay for a bacterial infection. (Radar Online)

Patients who are aggressive toward medical receptionists pose a “serious workplace safety concern” and can lead to workplace absenteeism and even staff leaving healthcare altogether. (Family Medicine and Community Health)

CMS said it would offer broad coverage of the Alzheimer’s drug lecanemab (Leqembi) now that it has full FDA approval.

Less than half of newly FDA approved drugs were rated as having a “high therapeutic value,” and only 34% of drugs’ supplemental indications achieved this rating. (The BMJ)

A Virginia doctor pleaded no contest to charges that he assaulted an employee who asked him how to get an elderly patient onto an exam table for an ECG; a charge that the physician prevented the employee from calling 911 was dropped. (NBC Washington)

Florida hospitals will now ask patients about their immigration status. (Miami Herald)

Over 20 pharmaceutical companies asked the Supreme Court to bar claims they funded terrorism during the war in Iraq, a claim stemming from a lower-court case where the companies were alleged to have made corrupt payments to obtain medical-supply contracts. (Reuters)

Midlife jawbone changes could be a precursor to height loss in women. (BMJ Open)

Novo Nordisk sued three Florida compounding pharmacies for illegally selling products containing semaglutide, the active ingredient in the company’s type 2 diabetes and weight loss drugs (Ozempic, Wegovy). (Reuters)

A West Virginia emergency medicine physician was the first board director appointed to a nonprofit in charge of distributing much of the state’s $1 billion-plus opioid settlement money. (AP)

What’s in that tap water? A governmental study found that nearly half of the tap water in the U.S. is contaminated with per- and polyfluorinated alkyl substances (PFAS), or so-called forever chemicals. (CNN)

A Wisconsin doctor surrendered her license following the death of a patient with late-stage endometrial cancer after managing the patient with “experimental treatment” as the cancer advanced. (Wisconsin State Journal)

The American Civil Liberties Union sued the District of Columbia over its use of armed police as first responders to mental health crises. (Washington Post)

South Carolina may have violated the Americans With Disabilities Act after failing to prevent the unnecessary institutionalization of adults with serious mental illness, said the Department of Justice. (The Hill)

Maine Gov. Janet Mills (D) is expected to sign a bill expanding abortion access later in pregnancy. (Bangor Daily News)

A new HHS initiative will use part of the president’s $2.7 billion workforce investment to grow the health workforce.

An investigational oral antirheumatic agent, bucillamine, flopped in a phase III trial for treating mild to moderate COVID-19, said Revive Therapeutics.

A biosimilar to adalimumab (Humira) will soon be available at Mark Cuban’s Cost Plus Drugs. (Reuters)

Six batches of albuterol sulfate inhalation aerosol were recalled due to a “container defect,” the U.S. unit of Indian drugmaker Cipla announced.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment